https://www.hcplive.com/view/guselkumab-delivers-long-term-improvements-in-tnf-na-ve-tnf-experienced-patients-with-psoriatic-arthritis
0
0
2/19/23 at 9:07pm
Organization
Hcplive.com
Author
Lana Pine
37 words
0
Comments
Guselkumab, an interleukin-23 inhibitor, demonstrated sustained improvements in both TNF-naïve and TNF-experienced patients with psoriatic arthritis.
You are the first to view
Create an account
or login to join the discussion